Efficacy of Adalimumab in Korean Patients with Crohn's Disease.
about
Understanding the complications of anti-tumor necrosis factor therapy in East Asian patients with inflammatory bowel disease.Systematic Review and Meta-analysis: Adalimumab Monotherapy Versus Combination Therapy with Immunomodulators for Induction and Maintenance of Remission and Response in Patients with Crohn's Disease.Risk factors and outcomes of acute lower gastrointestinal bleeding in intestinal Behçet's disease.Long-Term Outcomes of Adalimumab Treatment in 254 Patients with Crohn's Disease: A Hospital-Based Cohort Study from Korea.Comparative Study of Two Cohorts of Newly Diagnosed Crohn's Disease Demonstrates Change in Therapeutic Strategies.
P2860
Efficacy of Adalimumab in Korean Patients with Crohn's Disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Efficacy of Adalimumab in Korean Patients with Crohn's Disease.
@ast
Efficacy of Adalimumab in Korean Patients with Crohn's Disease.
@en
type
label
Efficacy of Adalimumab in Korean Patients with Crohn's Disease.
@ast
Efficacy of Adalimumab in Korean Patients with Crohn's Disease.
@en
prefLabel
Efficacy of Adalimumab in Korean Patients with Crohn's Disease.
@ast
Efficacy of Adalimumab in Korean Patients with Crohn's Disease.
@en
P2093
P2860
P356
P1433
P1476
Efficacy of Adalimumab in Korean Patients with Crohn's Disease.
@en
P2093
Hyun Jung Lee
Il Woong Sohn
Soo Jung Park
Sung Pil Hong
Sung Tae Kim
Tae Il Kim
Won Ho Kim
P2860
P304
P356
10.5009/GNL15165
P577
2015-10-19T00:00:00Z